VC-backed cell therapy AlloVir goes public
AlloVir Inc, a cell therapy company, has raised $276.25 million for its IPO after pricing its 16.25 million shares at $17 per share.
30 July 2020•3 mins read
AlloVir Inc, a cell therapy company, has raised $276.25 million for its IPO after pricing its 16.25 million shares at $17 per share.
